Company filings profile · CIK 0001808898
Benitec Biopharma Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Benitec Biopharma Inc. (BNTC): 4 filings in the last 90 days vs 5 in the prior 90 (filing-velocity cooling ↓ · 0.8×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 19, 2026. Source-linked, daily-refreshed.
Material 8-K events — Benitec Biopharma Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 29, 2026 | Departure/Election of Directors or Officers | ↗ |
| May 14, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Feb 12, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Dec 2, 2025 | Item 5.07 | ↗ |
| Nov 14, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 7, 2025 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
Watch Benitec Biopharma Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 14, 2026 | S-3 | S-3 | ↗ |
| Sep 14, 2026 | 10-K | 10-K | ↗ |
| Sep 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 30, 2026 | 4 | 4 | ↗ |
| May 29, 2026 | 8-K | Departure/Election of Directors or Officers | ↗ |
| May 28, 2026 | 4 | 4 | ↗ |
| May 28, 2026 | 3 | 3 | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 14, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 20, 2026 | 10-K/A | 10-K/A | ↗ |
| Feb 12, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Feb 12, 2026 | 10-Q | 10-Q | ↗ |
| Feb 11, 2026 | 424B3 | 424B3 | ↗ |
| Feb 10, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Feb 6, 2026 | CORRESP | ↗ | |
| Feb 6, 2026 | UPLOAD | ↗ | |
| Jan 30, 2026 | S-3 | S-3 | ↗ |
| Jan 29, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 26, 2026 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Dec 29, 2025 | 4 | ↗ | |
| Dec 22, 2025 | 4 | ↗ | |
| Dec 8, 2025 | SCHEDULE 13G/A | ↗ | |
| Dec 3, 2025 | SCHEDULE 13G | ↗ | |
| Dec 3, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Dec 3, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Dec 3, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Dec 3, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Dec 3, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Dec 2, 2025 | 8-K | Item 5.07 | ↗ |
| Nov 20, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Nov 20, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Nov 20, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Nov 14, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 14, 2025 | 10-Q | 10-Q | ↗ |
| Nov 12, 2025 | DEFA14A | DEFA14A | ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A | ↗ | |
| Nov 10, 2025 | 4 | ↗ | |
| Nov 7, 2025 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Nov 7, 2025 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | ↗ |
| Nov 7, 2025 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |